aod9604 and semaglutide AOD-9604 (10mg vials) Chevy Chase AOD 9604 Anti-Obesity

The increased NAD+ availability supports more efficient ATP (cellular energy) production, potentially translating to better endurance, improved workout performance, and faster recovery between training sessions

Avoid Vitamin C, AHAs, or strong actives during the healing window

This is because they have trouble absorbing B12 from food

Nausea (most common, typically dose-dependent and transient) Diarrhea or constipation during dose escalation Vomiting, especially when starting or increasing dose Reduced appetite and early satiety Injection site reactions (redness, bruising) Fatigue, particularly in early weeks Rare: Pancreatitis discontinue immediately with severe abdominal pain Rare: Thyroid C-cell effects (contraindicated with MEN2 or thyroid cancer history) AOD-9604 is a modified C-terminal fragment (residues 176191, Tyr-hGH177-191) of human growth hormone, studied for lipolytic and anti-obesity properties